# Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion

> **NCT07668323** · PHASE3 · RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 372 (estimated)

## Conditions studied

- Medium Vessel Occlusion
- Ischemic Stroke, Acute

## Interventions

- **DRUG:** Recombinant Tissue Plasminogen Activator (rt-PA)
- **PROCEDURE:** Intra-arterial Thrombolysis
- **DRUG:** Best Medical Management
- **PROCEDURE:** Rescue therapy

## Key facts

- **NCT ID:** NCT07668323
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-19
- **Primary completion:** 2029-01-31
- **Final completion:** 2029-05-31
- **Target enrollment:** 372 (ESTIMATED)
- **Last updated:** 2026-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668323, "Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*